1 Min Read
Jan 9 (Reuters) - Gilead Sciences
* CEO says planning Phase III trials of NASH drug in patients with advanced fibrosis Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.